D.A. Davidson & Co. Eagle Pharmaceuticals, Inc. Transaction History

D.A. Davidson & Co.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 04, 2018	SELL	$52.16 - $66.86 $224,287 - $287,498	-4,300 Closed	0 $0
Q3 2017 Nov 08, 2017	SELL	$46.62 - $60.36 $2,331 - $3,018	-50 Reduced 1.15%	4,300 $256,000
Q2 2017 Aug 11, 2017	BUY	N/A	4,350	4,350 $0

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $6.77M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.